Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of ≥325 μmol/L (≥19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000

Pediatrics

Volumn 122, Issue 1, 2008, Pages 119-124

  Jangaard, Krista A ^a,b   Fell, Deshayne B ^a   Dodds, Linda ^a   Allen, Alexander C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Department of Neonatal Perinatal Medicine ^*  (Canada)

Author keywords

Hyperbilirubinemia; Outcomes; Population Based

Indexed keywords

BILIRUBIN;

ARTICLE; AUTISM; BILIRUBIN BLOOD LEVEL; CANADA; CEREBRAL PALSY; CHILD HOSPITALIZATION; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; GESTATIONAL AGE; GROWTH RETARDATION; HEARING LOSS; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; INFANT; KERNICTERUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERM BIRTH; ATTENTION DEFICIT DISORDER; BLOOD; BREAST FEEDING; COMORBIDITY; DEVELOPMENTAL DISORDER; NEWBORN; NEWBORN JAUNDICE; STATISTICS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BILIRUBIN; BREAST FEEDING; CEREBRAL PALSY; COMORBIDITY; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; MALE; NOVA SCOTIA; TERM BIRTH;

EID: 48249140670     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-0967     Document Type: Article

References (25)

1. Holtrop PC, Maisels MJ. Hyperbilirubinemia in Intensive Care of the Fetus and Neonate. Philadelphia, PA: Mosby-Year Book; 1996:888-898
2. Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics. 1991;87(6):797-805
3. Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol. 1990;17(2):371-379
4. Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics. 1990;85(4):455-463
5. Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res. 2001;50(6):701-705
6. Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr. 1999;88(6):661-663
7. Deorari AK, Singh M, Ahuja GK, et al. One year outcome of babies with severe neonatal hyperbilirubinemia and reversible abnormality in brainstem auditory evoked responses. Indian Pediatr. 1994;31(8):915-921
8. Ozmert E, Erdem G, Topcu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 1996;85(12):1440-1444
9. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbiliru-binemia. Practice parameter: management of hyperbiliru-binemia in the healthy term newborn. Pediatrics. 1994;94(4):558-562
10. Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert. Oak Brook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations, Issue 18, April 1, 2001
11. Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics. 1999; 104(suppl 3):736
12. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89(10):1213-1217
13. Centers for Disease Control and Prevention. Kernicterus in full-term infants: United States 1994-1998. MMWR Morb Mortal Wkly Rep. 2001;50(23):491-494
14. Maisels MJ, Newman TB. Kernicterus in otherwise healthy breast-fed term newborns. Pediatrics. 1995;96(4):730-733
15. Hansen TW. Kernicterus in term and near-term infants: the specter walks again. Acta Paediatr. 2000;89(10):1155-1157
16. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107(5): 1075-1080
17. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993;92(5):651-657
18. Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889-1900
19. Grether JK, Cummins SK, Nelson KB. The California Cerebral Palsy Project. Paediatr Perinat Epidemiol. 1992;6(3):339-351
20. Cone-Wesson B, Vohr BR, Sininger YS, et al. Identification of neonatal hearing impairment: infants with hearing loss. Ear Hear. 2000;21(5):488-507
21. Boo NY, Oakes M, Lye MS, SaidH. Risk factors associated with hearing loss in term neonates with hyperbilirubinemia. J Trop Pediatr. 1994;40(4):194-197
22. Wong V, Chen WX, Wong KY. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol. 2006;21(4):309-315
23. Juul-Dam N, Townsend J, Courchensne E. Prenatal, perinatal and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics. 2001;107(4). Available at: www. pediatrics. org/cgi/content/full/107/4/e63
24. Croen LA, Yoshida CK, Odouli R, Newman TB. Neonatal hyperbilirubinemia and risk of autism spectrum disorders. Pediatrics. 2005;115(2). Available at: www. pediatrics. org/cgi/content/full/115/2/e135
25. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587-590